Wedbush Maintains Neutral on Nektar Therapeutics, Lowers Price Target to $80
Nektar Therapeutics NKTR
$66.61
▼ -2.87%
($-1.97)
Open
$68.00
Prev Close
$68.58
Day Range
$66.44 – $69.22
52W Range
$7.99 – $109.00
Market Cap
$2.25B
Beta
1.16
EPS (TTM)
$-8.32
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1994-05-03 |
| Shares Out. | 33,790,000 |
| Website | nektar.com/ ↗ |
| Phone | 13026587581 |
Nektar Therapeutics is a publicly traded company under the ticker symbol NKTR on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)